olorinab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for olorinab, covering 2022-10-12 to 2022-10-12. Get the full timeline:
Most recent: Clinical Trial Update: Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D) [Phase 2]